Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
Florence Njau(Medizinische Hochschule Hannover), Hermann Haller(Medizinische Hochschule Hannover)
Cited by 27
Related Papers
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
|Nephrology Dialysis Transplantation|2019|216
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
|Nephrology Dialysis Transplantation|2020|189
Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
|Scientific Reports|2019|61
Contributors
|Elsevier eBooks|2018|0